Living donor liver transplantation for hepatocellular carcinoma

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 165-179

  Lee, Sung Gyu ^a   Moon, Deok Bog ^a  

^a Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CALCINEURIN INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;

ARTICLE; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DECEASED DONOR LIVER TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR LIVER TRANSPLANTATION; MORBIDITY; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOPLASM RECURRENCE, LOCAL; NORTH AMERICA; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 84868319494     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_11     Document Type: Article

References (64)

1. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917 (Pubitemid 37518510)
2. Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127(suppl 1):S248-S260 (Pubitemid 39423394)
3. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699 (Pubitemid 26079803)
4. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394-1403 (Pubitemid 32496976)
5. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP (2007) Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 7:2587-2596 (Pubitemid 47561609)
6. Kaihara S, Kiuchi T, Ueda M et al (2003) Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 75:S37-S40 (Pubitemid 36222987)
7. Shimada M, Fujii M, Morine Y et al (2005) Living-donor liver transplantation: present status and future perspective. J Med Invest 52:22-32 (Pubitemid 40514413)
8. Kulik L, Abecassis M (2004) Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 127:S277-S282 (Pubitemid 39423397)
9. Vitale A et al (2010) Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc 42:1194-1196
10. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS et al (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7:1601-1608 (Pubitemid 46776250)
11. Hwang S, Lee SG, Lee YJ et al (2006) Lessons learned from 1,000 living donor liver transplantations in asingle center: howtomake living donations safe. Liver Transpl 12:920-927 (Pubitemid 43960367)
12. Lo CM (2003) Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation 75:S12-S15
13. Hsu HT, Hwang SL, Lee PH et al (2006) Impact of liver donation on quality of life and physical and psychological distress. Transplant Proc 38:2102-2105
14. de Villa V, Lo CM (2007) Liver transplantation for hepatocellular carcinoma in Asia. Oncologist 12(11):1321-1331 (Pubitemid 350232605)
15. Lee SG, Ahn CS, Ha TY, Moon DB, Choi KM, Song GW et al (2010) Liver transplantation for hepatocellular carcinoma: Korean experience. J Heaptobiliary Pancreat Sci 17:539-547
16. Rosemurgy A et al (2008) Frequency with which surgeons undertake pancreaticoduodenectomy continues to determine length of stay, hospital charges, and inhospital mortality. J Gastrointest Surg 12:442-449
17. Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2007) Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 245:51-58 (Pubitemid 46035435)
18. Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Nakanishi K, Yamashita K et al (2010) Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Sci 17:533-538
19. Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Yamashita K, Kamiyama T et al (2006) Living-donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13:393-397 (Pubitemid 44480240)
20. Sarasin FP, Majino PE, Llovet JM, Bruix J, Mentha G, Hadengue A (2001) Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 33:1073-1079 (Pubitemid 32378205)
21. Cheng SJ, Pratt DS, Freeman RB Jr, Kaplan MM, Wong JB (2001) Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 72:861-868 (Pubitemid 32879859)
22. Lo CM, Fan ST, Liu CL, Chan SC, Wong J (2004) The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 10:440-447 (Pubitemid 38380321)
23. Hwang S, Lee SG, Belghiti J (2010) Liver transplantation for HCC: its role. Eastern and Western perspectives. J Hepatobiliary Pancreat Sci 17:443-448
24. Lo CM, Fan ST, Liu CL et al (2007) Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94:78-86 (Pubitemid 46142736)
25. Todo S, Furukawa H (2004) The Japanese study group on organ transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240:451-459
26. Hwang S, Lee SG, Joh JW et al (2005) Liver transplantation for adult patients with hepatocellular arcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 11:1265-1272 (Pubitemid 41511942)
27. Shimada M, Fujii M, Morine Y et al (2005) Living-donor liver transplantation: present status and future perspective. J Med Invest 52:22-32 (Pubitemid 40514413)
28. Gondolesi GE, Roayaie S, Munoz L et al (2004) Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 239:142-149 (Pubitemid 38176346)
29. Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB et al (2008) Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 14:935-945 (Pubitemid 352003892)
30. Ito T, Takada Y, Ueda M et al (2007) Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 13:1637-1644
31. Taketomi A, Sanefuji K, Soejima Y et al (2009) Impact of des-gammacarboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 87(4):531-537
32. Sugawara Y, Tamura S, Makuuchi M (2007) Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 25:310-312 (Pubitemid 350014958)
33. Todo S, Furukawa H, Tada M (2007) Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 13(11 suppl 2):S48-S54 (Pubitemid 350168174)
34. Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST (2010) Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.J Hepatobiliary Pancreat Sci 17:548-554
35. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA et al (2001) Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 7:631-636 (Pubitemid 32677888)
36. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr et al (2005) The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 5:795-804 (Pubitemid 40461290)
37. Freeman RB Jr, Steffick DR, Guidinger MK, Farment DG, Berg CL, Merion RM (2008) Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 8: 958-976 (Pubitemid 351389064)
38. Belghiti J (2009) Resection and liver transplantation for HCC. J Gastroenterol 44(suppl 19):132-135
39. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F et al (2003) Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238:885-892
40. Adam R, Azoulay D, Castaing D (2003) Liver resection as a bridge to transplantation for hepatocellularcarcinoma on cirrhosis: a reasonable strategy? Ann Surg 238:508-518
41. Hwang S, Lee SG, Moon DB, Ahn CS, Kim KH, Lee YJ et al (2007) Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 13:741-746 (Pubitemid 46796546)
42. Laurent A, Tayar C, Andreoletti M et al (2009) Laparoscopic liver resection facilitates salvage liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 16:310-314
43. Majno PE, Adam R, Bismuth H et al (1997) Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226:688-701
44. Yao FY, Hirose R, LaBerge JM, Davern TJ III, Bass NM, Kerlan RK Jr et al (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11:1505-1514 (Pubitemid 43072626)
45. Chapman WC, Doyle MBM, Stuart JE, Vachharajani N, Crippin JS, Anderson CD et al (2008) Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 248:617-625
46. Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M et al (2008) Liver transplantation for hepatocellular carcinoma: Results of downstaging in patients initially outside the Milan selection criteria. Am J Transpl 8:2547-2557
47. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ 3rd, Bass NM, Feng S et al (2008) Excellent outcome following down-staging of hepatocelluar carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 48:819-827
48. Moon DB, Lee SG, Hwang S, Kim KH, Ahn CS, Ha TY et al (2010) The results of living donor liver transplantation for HCC satisfying Milan criteria after down-staging in patients initially outside Milan. Liver Transpl 16:S142 (in abstract)
49. Monmenti EP, Klintmalm GB (2002) Liver Transplantation in association with hepatocellular carcinoma: an update of the international tumor registry. Liver Transpl 8:736-748 (Pubitemid 35012281)
50. Llovet JM, Bruix J, Fuster J et al (1998) Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 27:1572-1577 (Pubitemid 28264681)
51. Shah SA, Tan JC, McGilvray ID et al (2006) Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 81:1633-1639 (Pubitemid 43948294)
52. Grasso A, Stigliano R, Morisco F et al (2006) Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explants study. Transplantation 81:1532-1541 (Pubitemid 43890890)
53. Tamura S, Kato T, Berho M et al (2001) Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 136:25-30
54. Yao FY, Ferrell I, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394-1403 (Pubitemid 32496976)
55. Regalia E, Fassati LR, Valente U et al (1998) Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg 5:29-34 (Pubitemid 128662554)
56. Roayaie S, Schwartz JD, Sung MW et al (2004) Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transplant 10:534-540 (Pubitemid 38443593)
57. Schwartz M, Konstadoulakis M, Roayaie S (2005) Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor? LiverTranspl 11:494-496 (Pubitemid 40704059)
58. Yamashiki N, Sugawara Y, Tamura S, Tateishi R, Yoshida H, Kaneko J et al (2010) Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma. Hepatol Res 40:278-286
59. Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW et al (2011) Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation. J Gastrointest Surg (in print)
60. Yoon DH, Ryoo BY, Ryu MH, Lee SG, Hwang S, Suh DJ et al (2010) Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Jpn J Clin Oncol 40:768-773
61. Alamo JM, Barrera L, Casado MD, Bernal C, Marin LM, Suarez G et al (2009) Efficacy, tolerance, and safety of mammalian target of rapamycin inhibitors as rescue immunosuppressants in liver transplantation. Transplant Proc 41:2181-2183
62. Wang Z, Zhou J, Fan J et al (2009) Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. J Cancer Res Clin Oncol 135:715-722
63. Toso C, Meeberg GA, Bigam DL et al (2007) De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 83:1162-1168 (Pubitemid 46743675)
64. Yi NJ, Suh KS, Cho JY, Kwon CH, Lee KW, Joh JW et al (2007) Recurrence of hepatitis B is associated with cumulated corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl 13:451-458 (Pubitemid 46444475)